In CLL patients, TCR signaling activation triggers a signaling cascade to activate ITK, promoting the differentiation of Th2 and Treg cells and inhibiting the differentiation of Th1 and cytotoxic CD8+ T cells (53, 54). This evidence concerns the gene ITK and B-cell chronic lymphocytic leukemia.